Cargando…

Distinct impact of IgG subclass on autoantibody pathogenicity in different IgG4-mediated diseases

IgG4 is the least potent human IgG subclass for the FcγR-mediated antibody effector function. Paradoxically, IgG4 is also the dominant IgG subclass of pathogenic autoantibodies in IgG4-mediated diseases. Here, we show that the IgG subclass and Fc-FcγR interaction have a distinct impact on the pathog...

Descripción completa

Detalles Bibliográficos
Autores principales: Bi, Yanxia, Su, Jian, Zhou, Shengru, Zhao, Yingjie, Zhang, Yan, Zhang, Huihui, Liu, Mingdong, Zhou, Aiwu, Xu, Jianrong, Pan, Meng, Zhao, Yiming, Li, Fubin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385207/
https://www.ncbi.nlm.nih.gov/pubmed/35920621
http://dx.doi.org/10.7554/eLife.76223
_version_ 1784769543166492672
author Bi, Yanxia
Su, Jian
Zhou, Shengru
Zhao, Yingjie
Zhang, Yan
Zhang, Huihui
Liu, Mingdong
Zhou, Aiwu
Xu, Jianrong
Pan, Meng
Zhao, Yiming
Li, Fubin
author_facet Bi, Yanxia
Su, Jian
Zhou, Shengru
Zhao, Yingjie
Zhang, Yan
Zhang, Huihui
Liu, Mingdong
Zhou, Aiwu
Xu, Jianrong
Pan, Meng
Zhao, Yiming
Li, Fubin
author_sort Bi, Yanxia
collection PubMed
description IgG4 is the least potent human IgG subclass for the FcγR-mediated antibody effector function. Paradoxically, IgG4 is also the dominant IgG subclass of pathogenic autoantibodies in IgG4-mediated diseases. Here, we show that the IgG subclass and Fc-FcγR interaction have a distinct impact on the pathogenic function of autoantibodies in different IgG4-mediated diseases in mouse models. While IgG4 and its weak Fc-FcγR interaction have an ameliorative role in the pathogenicity of anti-ADAMTS13 autoantibodies isolated from thrombotic thrombocytopenic purpura (TTP) patients, they have an unexpected exacerbating effect on anti-Dsg1 autoantibody pathogenicity in pemphigus foliaceus (PF) models. Strikingly, a non-pathogenic anti-Dsg1 antibody variant optimized for FcγR-mediated effector function can attenuate the skin lesions induced by pathogenic anti-Dsg1 antibodies by promoting the clearance of dead keratinocytes. These studies suggest that IgG effector function contributes to the clearance of autoantibody-Ag complexes, which is harmful in TTP, but beneficial in PF and may provide new therapeutic opportunity.
format Online
Article
Text
id pubmed-9385207
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher eLife Sciences Publications, Ltd
record_format MEDLINE/PubMed
spelling pubmed-93852072022-08-18 Distinct impact of IgG subclass on autoantibody pathogenicity in different IgG4-mediated diseases Bi, Yanxia Su, Jian Zhou, Shengru Zhao, Yingjie Zhang, Yan Zhang, Huihui Liu, Mingdong Zhou, Aiwu Xu, Jianrong Pan, Meng Zhao, Yiming Li, Fubin eLife Immunology and Inflammation IgG4 is the least potent human IgG subclass for the FcγR-mediated antibody effector function. Paradoxically, IgG4 is also the dominant IgG subclass of pathogenic autoantibodies in IgG4-mediated diseases. Here, we show that the IgG subclass and Fc-FcγR interaction have a distinct impact on the pathogenic function of autoantibodies in different IgG4-mediated diseases in mouse models. While IgG4 and its weak Fc-FcγR interaction have an ameliorative role in the pathogenicity of anti-ADAMTS13 autoantibodies isolated from thrombotic thrombocytopenic purpura (TTP) patients, they have an unexpected exacerbating effect on anti-Dsg1 autoantibody pathogenicity in pemphigus foliaceus (PF) models. Strikingly, a non-pathogenic anti-Dsg1 antibody variant optimized for FcγR-mediated effector function can attenuate the skin lesions induced by pathogenic anti-Dsg1 antibodies by promoting the clearance of dead keratinocytes. These studies suggest that IgG effector function contributes to the clearance of autoantibody-Ag complexes, which is harmful in TTP, but beneficial in PF and may provide new therapeutic opportunity. eLife Sciences Publications, Ltd 2022-08-03 /pmc/articles/PMC9385207/ /pubmed/35920621 http://dx.doi.org/10.7554/eLife.76223 Text en © 2022, Bi et al https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Immunology and Inflammation
Bi, Yanxia
Su, Jian
Zhou, Shengru
Zhao, Yingjie
Zhang, Yan
Zhang, Huihui
Liu, Mingdong
Zhou, Aiwu
Xu, Jianrong
Pan, Meng
Zhao, Yiming
Li, Fubin
Distinct impact of IgG subclass on autoantibody pathogenicity in different IgG4-mediated diseases
title Distinct impact of IgG subclass on autoantibody pathogenicity in different IgG4-mediated diseases
title_full Distinct impact of IgG subclass on autoantibody pathogenicity in different IgG4-mediated diseases
title_fullStr Distinct impact of IgG subclass on autoantibody pathogenicity in different IgG4-mediated diseases
title_full_unstemmed Distinct impact of IgG subclass on autoantibody pathogenicity in different IgG4-mediated diseases
title_short Distinct impact of IgG subclass on autoantibody pathogenicity in different IgG4-mediated diseases
title_sort distinct impact of igg subclass on autoantibody pathogenicity in different igg4-mediated diseases
topic Immunology and Inflammation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385207/
https://www.ncbi.nlm.nih.gov/pubmed/35920621
http://dx.doi.org/10.7554/eLife.76223
work_keys_str_mv AT biyanxia distinctimpactofiggsubclassonautoantibodypathogenicityindifferentigg4mediateddiseases
AT sujian distinctimpactofiggsubclassonautoantibodypathogenicityindifferentigg4mediateddiseases
AT zhoushengru distinctimpactofiggsubclassonautoantibodypathogenicityindifferentigg4mediateddiseases
AT zhaoyingjie distinctimpactofiggsubclassonautoantibodypathogenicityindifferentigg4mediateddiseases
AT zhangyan distinctimpactofiggsubclassonautoantibodypathogenicityindifferentigg4mediateddiseases
AT zhanghuihui distinctimpactofiggsubclassonautoantibodypathogenicityindifferentigg4mediateddiseases
AT liumingdong distinctimpactofiggsubclassonautoantibodypathogenicityindifferentigg4mediateddiseases
AT zhouaiwu distinctimpactofiggsubclassonautoantibodypathogenicityindifferentigg4mediateddiseases
AT xujianrong distinctimpactofiggsubclassonautoantibodypathogenicityindifferentigg4mediateddiseases
AT panmeng distinctimpactofiggsubclassonautoantibodypathogenicityindifferentigg4mediateddiseases
AT zhaoyiming distinctimpactofiggsubclassonautoantibodypathogenicityindifferentigg4mediateddiseases
AT lifubin distinctimpactofiggsubclassonautoantibodypathogenicityindifferentigg4mediateddiseases